Taro Pharmaceutical Industries Ltd. EPS - Earnings per Share 2010-2023 | TARO
Taro Pharmaceutical Industries Ltd. eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Taro Pharmaceutical Industries Ltd. Annual EPS |
2024 |
$1.43 |
2023 |
$0.68 |
2022 |
$1.55 |
2021 |
$-10.12 |
2020 |
$6.35 |
2019 |
$7.23 |
2018 |
$5.26 |
2017 |
$11.05 |
2016 |
$12.62 |
2015 |
$11.31 |
2014 |
$8.14 |
2013 |
$5.95 |
2012 |
$4.11 |
2011 |
$0.00 |
2011 |
$1.27 |
2010 |
$0.00 |
2010 |
$1.09 |
2009 |
$1.27 |
Taro Pharmaceutical Industries Ltd. Quarterly EPS |
2023-12-31 |
$0.54 |
2023-09-30 |
$0.23 |
2023-06-30 |
$0.27 |
2023-03-31 |
$0.19 |
2022-12-31 |
$0.19 |
2022-09-30 |
$-0.07 |
2022-06-30 |
$0.37 |
2022-03-31 |
$0.73 |
2021-12-31 |
$0.70 |
2021-09-30 |
$0.62 |
2021-06-30 |
$-0.50 |
2021-03-31 |
$-0.79 |
2020-12-31 |
$0.86 |
2020-09-30 |
$1.18 |
2020-06-30 |
$-11.37 |
2020-03-31 |
$1.41 |
2019-12-31 |
$1.76 |
2019-09-30 |
$1.46 |
2019-06-30 |
$1.72 |
2019-03-31 |
$1.52 |
2018-12-31 |
$2.40 |
2018-09-30 |
$1.60 |
2018-06-30 |
$1.71 |
2018-03-31 |
$2.16 |
2017-12-31 |
$0.45 |
2017-09-30 |
$1.30 |
2017-06-30 |
$1.35 |
2017-03-31 |
$2.04 |
2016-12-31 |
$3.42 |
2016-09-30 |
$3.00 |
2016-06-30 |
$2.59 |
2016-03-31 |
$2.68 |
2015-12-31 |
$4.41 |
2015-09-30 |
$3.11 |
2015-06-30 |
$2.42 |
2015-03-31 |
$3.56 |
2014-12-31 |
$3.33 |
2014-09-30 |
$3.35 |
2014-06-30 |
$1.08 |
2014-03-31 |
$2.10 |
2013-12-31 |
$2.59 |
2013-09-30 |
$2.15 |
2013-06-30 |
$1.32 |
2013-03-31 |
$1.10 |
2012-12-31 |
$1.98 |
2012-09-30 |
$1.46 |
2012-06-30 |
$1.41 |
2012-03-31 |
$1.06 |
2011-12-31 |
$1.40 |
2011-09-30 |
$1.32 |
2011-06-30 |
$0.80 |
2011-03-31 |
$0.58 |
2010-12-31 |
$0.11 |
2010-09-30 |
$0.46 |
2010-06-30 |
$0.46 |
2010-03-31 |
$0.25 |
2009-12-31 |
$0.00 |
2009-09-30 |
$0.24 |
2009-06-30 |
$0.31 |
2009-03-31 |
$0.00 |